XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Intangible Assets, Net (Tables)
6 Months Ended
Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of changes in the carrying amount of goodwill
Changes in the carrying amount of goodwill were as follows:
(In millions)U.S. PharmaceuticalPrescription Technology SolutionsMedical-Surgical SolutionsInternationalTotal
Balance, March 31, 2021$3,963 $1,542 $2,453 $1,535 $9,493 
Goodwill acquired— — — 
Foreign currency translation adjustments, net(9)— — (15)(24)
Balance, September 30, 2021$3,954 $1,542 $2,453 $1,524 $9,473 
Schedule of information regarding intangible assets
Information regarding intangible assets is as follows:
 September 30, 2021March 31, 2021
(Dollars in millions)Weighted-
Average
Remaining
Amortization
Period
(Years)
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Customer relationships12$3,241 $(2,017)$1,224 $3,739 $(2,269)$1,470 
Service agreements101,082 (542)540 1,081 (513)568 
Pharmacy licenses22308 (209)99 497 (244)253 
Trademarks and trade names12872 (394)478 925 (394)531 
Technology3136 (116)20 150 (122)28 
Other7255 (231)24 254 (226)28 
Total $5,894 $(3,509)$2,385 
(1)
$6,646 $(3,768)$2,878 
(1)Excludes net intangible assets of approximately $279 million related to the E.U. disposal group, as discussed in more detail in Financial Note 2, “Held for Sale.” This amount was included under the caption “Assets held for sale” in the Condensed Consolidated Balance Sheet as of September 30, 2021. Amortization of these assets ceased upon reclassification to Assets held for sale in the second quarter of 2022.